Our Team

Anat is CFO of Averna Therapeutics and a venture partner at OrbiMed, bringing over 18 years of senior financial and operational experience in biotechnology. Her background includes fundraising, licensing, partnerships, and M&A transactions totaling over $1 billion. She has led finance and operations functions across organizations and fostered cross-functional collaboration to drive growth and value creation. Prior to Averna, she was CFO of Adicet Bio and held CFO roles at ImmPact Bio (acquired by Lyell), cCam Biotherapeutics (acquired by Merck), Keystone Heart, RDD Pharma, OticPharma, NasVax, and Elutex.

She is a Certified Public Accountant and holds an MA in law and a BA in finance and economics.